NCT02997956 2017-04-25Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)University of Michigan Rogel Cancer CenterPhase 1/2 Withdrawn